Generate Biomedicines, Inc. (GENB)
NASDAQ: GENB · USD
$14.0
+0.95 (+7.3%)· Recorded snapshot
Coverage state: Market snapshot only — no published research
Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.
On-demand research
Generate the first GENB analysis
Start the full research workflow when this ticker is ready in our data system.
| Market cap | 1.8B | |
|---|---|---|
| Revenue (ttm) | 30.3M | |
| Net income (ttm) | -265.4M | |
| EPS (ttm) | -$4.57 | |
| Shares out | 128.2M | |
| Volume | 356,926 | |
| Price target | $25.4 | +81.0% |
Market data
Price
Recent price action with selectable time range.
Financial snapshot
- Revenue (ttm)
- 30.3M
- Net income (ttm)
- -265.4M
- EPS (ttm)
- -$4.57
- Market cap
- 1.8B
Fair-value bridge
- Current price
- $14.0
Analyst consensus
Recommendation
Strong Buy
Price target
$25.4
+81.0%
In the news
Latest news · GENB
Recent company headlines from major financial publishers.
Valuation
- Market cap
- 1.8B
- P/S
- 59.4x
- P/B
- 3.5x
Profitability
- Operating margin
- -828.5%
Balance sheet
- Debt / equity
- 0.13
- Current ratio
- 9.17
- Quick ratio
- 8.85
Trading
- Volume
- 356,926
- Dividend yield
- 0.0%